Skip to content
naulon

Not checkedNot checked for notices yet.

Prognostic value of 18F-FDG PET-CT for indolent B-cell lymphoma: analysis of 98 cases

WAN Xin, WANG Shunan, GUO Wei and 2 more

Di-san junyi daxue xuebao · 2019

doi:10.16016/j.1000-5404.201810180 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Objective To investigate the value of the maximun standardized uptake value (SUVmax) in 18F-FDG PET-CT before treatment in predicting the survival outcomes of patients with indolent B-cell lymphoma (B-iNHL). Methods The clinical data were collected from 98 patients with B-iNHL diagnosed and treated in our hospital from January, 2012 to December, 2017. All the patients, including 43 with follicular lymphoma and 55 with nonfollicular lymphoma, underwent 18F-FDG PET-CT before treatment, and the correlation of SUVmax with the survival outcomes of the patients were analyzed. Results The median SUVmax was 6.8 (range 1.8-25.4) in the overall 98 patients with B-iNHL. The median SUVmax was significantly higher in patients with follicular lymphoma than those with nonfollicular lymphoma [7.8 (3.6-20.3) vs 5.3 (1.8-25.4)], P=0.001). According to the level of SUVmax, the 98 patients were divided into high SUVmax (> 7.25; n=39) group and low SUVmax (≤7.25; n=59) group, and univariate and multivariate analyses showed that a SUVmax > 7.25 was an independent risk factor that affected progression-free survival (PFS) and overall survival (OS) of the patients (P < 0.05). Compared with those with low SUVmax before treatment, the patients with high SUVmax had a significantly lower 3-year estimated PFS rate (43.8% vs 85.9%, P < 0.05) and 3-year estimated OS rate (79.0% vs 98.3%, P < 0.05). Nine patients in high SUVmax group and 1 in low SUVmax group died, showing a significant difference in the mortality rate between the two groups (9/39 vs 1/59, 23.1% vs 1.7%, P=0.001). Conclusion SUVmax in 18F-FDG PET-CT is an independent risk factor affecting PFS and OS of the patients with B-iNHL and can be used as a predictor of the survival outcomes of the patients. indolent lymphoma B cells

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.